Vice Dean School of Medicine and Professor of Internal Medicine, UC Davis School of Medicine
Oncology
Dr. Frederick J. Meyers, MD
|
|
Give Review
Dr. Frederick J. Meyers works in the field of Oncology. He went to University of California San Francisco School of Medicine. University of California San Francisco School of Medicine is a top medical college. University of California San Francisco School of Medicine is ranked 3 in research and 3 in primary care medicine Frederick Meyers is a published doctor and has 36 publications published. The lastest was: 'The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiative.' Frederick Meyers accepts Medicare.
Publications
- The origin and implementation of the Broadening Experiences in Scientific Training programs: an NIH common fund initiative.
- Graduate Medical Education Reform: Moving the Elephant.
- A transparent oversight policy for human anatomical specimen management: the university of california, davis experience.
- Strengthening the Career Development of Clinical Translational Scientist Trainees: A Consensus Statement of the Clinical Translational Science Award (CTSA) Research Ed...
- Creating the future biomedical research workforce.
- Nomogram to Predict Risk of 30-Day Morbidity and Mortality for Patients With Disseminated Malignancy Undergoing Surgical Intervention.
- Effects of a Problem-Solving Intervention (COPE) on Quality of Life for Patients with Advanced Cancer on Clinical Trials and their Caregivers: Simultaneous Care Educat...
- Palliative care in urology.
- Recombinant innovation and translational science trainees.
- Cardiovascular Disease in women--challenges deserving a comprehensive translational approach.
- The utility of the model for end-stage liver Disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.
- Diverse populations can use hospice services appropriately.
- Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma.
- The immunobiology of mushrooms.
- Palliative care for prison inmates: "don't let me die in prison".
- Can patient coaching reduce racial/ethnic disparities in cancer pain control? Secondary Analysis of a randomized controlled trial.
- Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic Cancer pain: a single-institution experience and review of the literature.
- Medical and surgical palliative care of patients with urological Malignancies.
- Confronting the brutal facts in health care.
- An approach to develop effective health care decision making for women in prison.
- Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
- An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of Cancer clinical trial costs in California.
- Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.
- Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
- Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell Carcinoma.
- The TLC model of palliative care in the elderly: preliminary application in the assisted living setting.
- Centers, Institutes, and the future of clinical departments: part I.
- Population-based maximum tolerated dose of irinotecan and carboplatin.
- Simultaneous care: Disease treatment and palliative care throughout illness.
- Prison hospice and pastoral care services in California.
- Does HER2/neu expression provide prognostic information in patients with advanced urothelial Carcinoma?
- Hospice care for the incarcerated in the United States: an introduction.
- HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.
- Combined modality radioimmunotherapy for human prostate Cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
- Commentary: decentralizing quality improvement.
Schools
University Of California San Francisco School Of Medicine
University Of California Davis Med Center
Conditions Treated
- Anal and Rectal Cancer
- Anemia
- Antiphospholipid Syndrome (APS)
- Breast Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of California Davis -
University of California San Francisco School of Medicine
Hospital
-
University of California, Davis Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1881671675 |
| Last Name Of The Provider | MEYERS |
| First Name Of The Provider | FREDERICK |
| View All |
Similar Doctors
|
Dr. Robert E. Quadro, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanna L. Welborn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sidney A. Scudder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. I-Yeh Gong, MD |
|
Dr. M R. Goldberg, MD |
|
|
Dr. Cheryl C. Ho, MD |
|
|
Dr. Karen L. Kelly, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zarir E. Karanjawala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy Q. Lei, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ashok P. Pai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hooman H. Rashidi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ronald M. Wisdom, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Colin P. Spears, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mehrdad Abedi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randeep S. Sangha, MD |
|
|
Edith A. Perez |